Hanne F Harbo
Overview
Explore the profile of Hanne F Harbo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
4356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eriksson A, Emini N, Harbo H, Berge T
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940946
The genetic landscape of multiple sclerosis (MS) has been extensively mapped, yielding significant insights into the molecular mechanisms of the disorder. Early studies highlighted key genes associated with the immune...
2.
Pontillo G, Prados F, Wink A, Kanber B, Bisecco A, Broeders T, et al.
Hum Brain Mapp
. 2024 Dec;
46(1):e70107.
PMID: 39740239
Disruptions to brain networks, measured using structural (sMRI), diffusion (dMRI), or functional (fMRI) MRI, have been shown in people with multiple sclerosis (PwMS), highlighting the relevance of regions in the...
3.
Marti-Juan G, Sastre-Garriga J, Vidal-Jordana A, Llufriu S, Martinez-Heras E, Groppa S, et al.
Netw Neurosci
. 2024 Dec;
8(4):1545-1562.
PMID: 39735510
Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system. Structures affected in MS include the corpus callosum, connecting the hemispheres. Studies have shown that in mammalian...
4.
Lindland E, Rovang M, Solheim A, Andreassen S, Skarstein I, Dareez N, et al.
Neuroradiology
. 2024 Oct;
67(1):37-48.
PMID: 39422730
Purpose: Many consider white matter hyperintensities (WMHs) to be important imaging findings in neuroborreliosis. However, evidence regarding association with WMHs is of low quality. The objective was to investigate WMHs...
5.
Kennedy K, Kerlero de Rosbo N, Uccelli A, Cellerino M, Ivaldi F, Contini P, et al.
PLoS Comput Biol
. 2024 Feb;
20(2):e1010980.
PMID: 38329927
Complex diseases such as Multiple Sclerosis (MS) cover a wide range of biological scales, from genes and proteins to cells and tissues, up to the full organism. In fact, any...
6.
Andorra M, Freire A, Zubizarreta I, Kerlero de Rosbo N, Bos S, Rinas M, et al.
J Neurol
. 2023 Dec;
271(3):1133-1149.
PMID: 38133801
Background: Multiple sclerosis patients would benefit from machine learning algorithms that integrates clinical, imaging and multimodal biomarkers to define the risk of disease activity. Methods: We have analysed a prospective...
7.
Lindland E, Solheim A, Andreassen S, Bugge R, Eikeland R, Reiso H, et al.
Eur Radiol Exp
. 2023 Sep;
7(1):52.
PMID: 37710058
Background: Main aim was assessment of regional blood-brain barrier (BBB) function by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in patients with neuroborreliosis. Secondary aim was to study the correlation of...
8.
Fleischer V, Gonzalez-Escamilla G, Pareto D, Rovira A, Sastre-Garriga J, Sowa P, et al.
Brain
. 2023 Aug;
147(1):135-146.
PMID: 37642541
The identification of prognostic markers in early multiple sclerosis (MS) is challenging and requires reliable measures that robustly predict future disease trajectories. Ideally, such measures should make inferences at the...
9.
Brune-Ingebretsen S, Hogestol E, Kerlero de Rosbo N, Berg-Hansen P, Brunborg C, Blennow K, et al.
J Neuroimmunol
. 2023 Aug;
382:578175.
PMID: 37573634
Changes is lymphocyte subpopulations in peripheral blood have been proposed as biomarkers for evaluation of disease activity in multiple sclerosis (MS). Serum neurofilament light chain (sNfL) is a biomarker reflecting...
10.
Wolf A, Ravussin A, Konig M, Overas M, Solum G, Kjonstad I, et al.
JCI Insight
. 2023 May;
8(12).
PMID: 37159281
Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-targeting immunotherapies, including anti-CD20 treatments and sphingosine-1-phosphate receptor (S1PR)...